191 related articles for article (PubMed ID: 38706901)
1. Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity.
Huang X; Yi G; Xu J; Gou S; Chen H; Chen X; Quan X; Xie L; Teichmann AT; Yang G; Chi H; Wang Q
J Cancer; 2024; 15(10):3095-3113. PubMed ID: 38706901
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhou S; Zhang W; Cao W; Jin Q; Jiang X; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Qi J; Tong Z
Front Oncol; 2022; 12():1049773. PubMed ID: 36408157
[TBL] [Abstract][Full Text] [Related]
3. Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer.
Liang H; Xiang L; Wu H; Liu Y; Tian W; Zeng J
Front Pharmacol; 2023; 14():1135626. PubMed ID: 37021052
[No Abstract] [Full Text] [Related]
4. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
5. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
He JY; Li ZM; Chen YT; Zhao BH; Yu C
Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688
[TBL] [Abstract][Full Text] [Related]
6. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
7. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S
Front Oncol; 2022; 12():1011000. PubMed ID: 36185274
[TBL] [Abstract][Full Text] [Related]
9. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
10. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity.
Xu J; Huang X; Gou S; Luo H; Zeng S; Zhang Q; Wu Q; Chi H; Yang G
J Cancer; 2024; 15(9):2788-2804. PubMed ID: 38577592
[No Abstract] [Full Text] [Related]
12. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
Hu D; Zhang Z; Zhang Y; Huang K; Li X
Front Genet; 2023; 14():1137995. PubMed ID: 37007965
[No Abstract] [Full Text] [Related]
13. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Dong Y; Wen W; Yuan T; Liu L; Li X
Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
Chen X; Dong X; Li H; Wu T; Liu H; Wu J; Ge W; Hao L; Zhang Z
Cancer Cell Int; 2024 Feb; 24(1):80. PubMed ID: 38383371
[TBL] [Abstract][Full Text] [Related]
15. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
17. Aggrephagy-related LncRNAs index: A predictor for HCC prognosis, immunotherapy efficacy, and chemosensitivity.
Feng S; Yang C; Wang J; Fan X; Ying X
Technol Health Care; 2023; 31(4):1429-1449. PubMed ID: 36872811
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive RNA Expression Signature for Cervical Squamous Cell Carcinoma Prognosis.
Xiong J; Guo S; Bing Z; Su Y; Guo L
Front Genet; 2018; 9():696. PubMed ID: 30662454
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]